ESOMEPRAZOLE MAGNESIUM - esomeprazole magnesium capsule, delayed release
LEADER/ CARDINAL HEALTH 110, INC.
----------
Active ingredient (in each capsule)
*Esomeprazole 20 mg
(Each delayed-release capsule corresponds to 21.75 mg esomeprazole magnesium dihydrate USP)
Allergy alert:
■ Do not use if you are allergic to esomeprazole.
■ Esomeprazole may cause severe skin reactions.
Symptoms may include: ■ Skin reddening ■ blisters ■ rash. If an allergic reaction occurs, stop use and seek medical help right away.
These may be signs of a serious condition. See your doctor.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
14-Day Course of Treatment
Repeated 14-Day Courses (if needed)
Other information
colloidal silicon dioxide, FD&C blue no.1, gelatin, hydroxypropyl cellulose, hypromellose, magnesium carbonate, magnesium oxide, methacrylic acid and ethyl acrylate copolymer dispersion, mono and di glycerides, polysorbate 80, propylene glycol, shellac, sodium lauryl sulfate, strong ammonia solution, sugar spheres (which contains starch (maize) and sucrose), talc, titanium dioxide, triethyl citrate and yellow iron oxide.
Questions or comments?
call 1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST)
DISTRIBUTED BY CARDINAL HEALTH
DUBLIN, OHIO 43017
www.myleader.com 1-800-200-6313
Made in India
LEADER™
NDC 70000-0731-2
24 Hour Capsules
Esomeprazole Magnesium
Delayed-Release Capsules USP, 20 mg* | Acid Reducer
Treats Frequent Heartburn
May Take 1 to 4 Days for Full Effect
14 CAPSULES
One 14-Day Course of Treatment
SEE NEW WARNING INFORMATION
LEADER™
NDC 70000-0731-1
24 Hour Capsules
Esomeprazole
Magnesium
Delayed-Release Capsules USP, 20 mg* | Acid Reducer
COMPARE TO
NEXIUM® 24HR
active ingredient**
Treats Frequent Heartburn
May Take 1 to 4 Days for Full Effect
28 CAPSULES
(2 bottles of 14 each)
Two 14-Day Courses of Treatment
Actual Size
100% Money
Back Guarantee
ESOMEPRAZOLE MAGNESIUM
esomeprazole magnesium capsule, delayed release |
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
Labeler - LEADER/ CARDINAL HEALTH 110, INC. (063997360) |
Registrant - Aurohealth LLC (078728447) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Aurobindo Pharma Limited | 650381903 | ANALYSIS(70000-0731) , MANUFACTURE(70000-0731) |